Re: Institute for Clinical Evaluative Sciences report on SSRI elder's suicide

May 4, 2006

Imagine the amplified side effects when a

suicide/homicide victim , was abruptly taken off

decades of nuroleptic drugs , then put on

SSRIs.

Then the two , three or four different

kinds of SSRI drugs at once .

The one didnt work so try this , then

another , and another .

Most people dont understand what control it

takes the user, to keep from doing himself, or

others while using this un natural poison .

The doctors know how these drugs affect the user,

and prescribe it,

per the side effects given .

Its not left to chance.

Psychiatrists are purposeful

abusers.

Giving the suicidal/homicidal side

effects, is part of their anti therapy.

Little in Psychiatry is left to chance .

They have studied us, and the poison to a

fine art .

The DSM , is the

" Psychiatric Poisoners Handbook " .

The art of slow death , and destructive

medical mal practice .

They know all about SSRIs making us sick .

They like to see it .

They dont withdraw the med

in lock up/controled studies.

Psychiatry will just adjust it ,

add to it, or change it,

but never stop pushing it .

They would loose too much money.

They are that greedy.

Psychiatry , does not care .

>

> SSRI antidepressants associated with increased risk of suicide in

> the first month of therapy

>

> MEDIA RELEASE

>

> http://www.ices.on.ca/webpage.cfm?

> site_id=1 & org_id=117 & morg_id=0 & gsec_id=3086 & item_id=3550 & utility_link

> _id=3086

>

> Toronto, May 01, 2006

>

> A new ICES study shows that elderly patients who take the

> antidepressants known as selective serotonin reuptake inhibitors

> (SSRIs) are nearly five times more likely to commit suicide during

> the first month of therapy compared to those prescribed other

> antidepressants.

>

> " Earlier case reports describe intense suicidal thoughts during the

> first weeks of SSRI therapy. However, this is a challenging problem

> to study on a larger scale because it is difficult to separate the

> role of depression from a possible adverse effect of medication, "

> said lead author and ICES Scientist Dr. Juurlink.

>

> " Recent attention has focused on the possible risks of

> antidepressants in children, but no studies have specifically

> addressed the safety of SSRIs in older adults, despite the high

> frequency with which antidepressants are used in this group. "

>

> To explore this issue, ICES investigators linked coroner's records

> with patient prescription data, physician billing claims, and

> hospitalization data for Ontario residents aged 66 years and older

> between 1992 and 2000 to determine the odds of suicide for people

> prescribed SSRIs compared to those prescribed a non-SSRI

> antidepressant. The study included a total of 1,142 suicides in

> older Ontarians.

>

> The researchers examined the type and timing of antidepressant

> treatment in the six months before suicide. They found that the

> majority of patients who committed suicide were not treated with an

> antidepressant. However, among those who were, the risk with SSRIs

> was almost five times higher than non-SSRIs during the first month

> of treatment. This risk persisted regardless of whether the patient

> had recently been diagnosed with depression or had been receiving

> psychiatric care for a period of time prior to the therapy.

> Moreover, suicides of a violent nature (e.g., involving firearms and

> jumping from heights) were especially common during the initial

> month of SSRI therapy. However, after the first month of therapy,

> no heightened risk of suicide with SSRI antidepressants was evident.

>

> " While the initiation of SSRI therapy is associated with a

> significant increased risk of suicide in this group, the overall

> risk is low. Therefore, patients who are responding well to SSRI

> antidepressants should not discontinue therapy, and individuals with

> depression must not be deterred from seeking appropriate treatment

> based on our findings, " said Dr. Juurlink.

>

> " It is important to note that our study also indicated that the

> overwhelming majority of patients treated with SSRIs do not commit

> suicide. In patients with major depression, the hazards of

> undertreatment almost certainly outweigh the risks of therapy. The

> results of this study reaffirm the need for clinicians to reserve

> SSRI antidepressants for patients with established uses, to monitor

> patients closely after commencing treatment, and to inform patients

> and their families of the possible emergence of suicidal behaviours

> during the initial weeks of therapy. "

>

> The study, " The risk of suicide with selective serotonin reuptake

> inhibitors in the elderly " , is in the May 2006 issue of the American

> Journal of Psychiatry.

>

> Author affiliations: ICES (all authors); Departments of Medicine

> (Drs. Juurlink and Redelmeier), and the Clinical Epidemiology and

> Healthcare Research Program (Drs. Juurlink and Redelmeier),

> University of Toronto; Divisions of General Internal Medicine (Drs.

> Juurlink and Redelmeier), and Clinical Pharmacology (Dr. Juurlink),

> Sunnybrook Health Sciences Centre.

>

> ICES is an independent, non-profit organization that uses population-

> based health information to produce knowledge on a broad range of

> health care issues. Our unbiased evidence provides measures of

> health system performance, a clearer understanding of the shifting

> health care needs of Ontarians, and a stimulus for discussion of

> practical solutions to optimize scarce resources. ICES knowledge is

> highly regarded in Canada and abroad, and is widely used by

> government, hospitals, planners, and practitioners to make decisions

> about care delivery and to develop policy.

>

May 4, 2006